Home Newsfeeds Piper Sandler Maintains Neutral on Cloudflare, Raises Price Target to $73

Piper Sandler Maintains Neutral on Cloudflare, Raises Price Target to $73

Piper Sandler analyst James Fish maintains Cloudflare (NYSE:NET) with a Neutral and raises the price target from $57 to $73.

byBenzinga Newsdesk

August 5, 2022

1 minute read

Piper Sandler analyst James Fish maintains Cloudflare (NYSE:NET) with a Neutral and raises the price target from $57 to $73.

GLJ Research Maintains Sell on Canadian Solar, Lowers Price Target to $12.22

By Benzinga Newsdesk

January 23, 8:52 AM

GLJ Research analyst Gordon Johnson maintains Canadian Solar (NASDAQ:CSIQ) with a Sell and lowers the price target from $18.39 to $12.22.

CSIQ

Pharmacy Chain Operator Walgreens’ CEO Rosalind Brewer Steps Down, Stock Down Over 45% Since Her Appointment

By Vandana Singh

September 1, 8:38 AM

Walgreens Boots Alliance Inc's (NASDAQ: WBA) CEO has agreed to step down as CEO and board member as of August 31, 2023.

WBA

UPS Buys MNX Global Logistics To Strengthen Presence In Healthcare Industry

By Lekha Gupta

September 28, 11:44 AM

United Parcel Service Inc (NYSE: UPS) penned a deal to acquire MNX Global Logistics (MNX)

UPS

Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven To Stop Disruptive Bleeding

By Benzinga Newsdesk

November 15, 10:07 AM

Addition of hemostatic patch complements Ethicon's comprehensive Biosurgery portfolio and ability to address critical unmet needs in controlling bleedingEthicon*, a Johnson & Johnson MedTech company**,

JNJ

Piper Sandler Maintains Neutral on Cloudflare, Raises Price Target to $73

Related Posts

GLJ Research Maintains Sell on Canadian Solar, Lowers Price Target to $12.22

Pharmacy Chain Operator Walgreens’ CEO Rosalind Brewer Steps Down, Stock Down Over 45% Since Her Appointment

UPS Buys MNX Global Logistics To Strengthen Presence In Healthcare Industry

Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven To Stop Disruptive Bleeding